Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1997 5
1998 4
1999 1
2000 1
2001 1
2002 3
2004 2
2005 3
2006 7
2007 6
2008 4
2009 7
2010 7
2011 9
2012 7
2013 8
2014 11
2015 5
2016 6
2017 6
2018 8
2019 12
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27756713

116 results
Results by year
Filters applied: . Clear all
Page 1
Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People's Democratic Republic: a cross-sectional study.
Evdokimov K, Sayasinh K, Nouanthong P, Vilivong K, Samountry B, Phonekeo D, Strobel M, Haegeman F, Heimann P, Muller CP, Black AP. Evdokimov K, et al. Clin Microbiol Infect. 2017 Mar;23(3):197-202. doi: 10.1016/j.cmi.2016.10.007. Epub 2016 Oct 15. Clin Microbiol Infect. 2017. PMID: 27756713 Free article.
Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.
Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, Yela U, Herzog C, Aeberhard U, Spyr C. Gentile A, et al. Int J Infect Dis. 2011 Jan;15(1):e24-9. doi: 10.1016/j.ijid.2010.09.004. Epub 2010 Nov 18. Int J Infect Dis. 2011. PMID: 21093342 Free article. Clinical Trial.
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A. Halperin SA, et al. Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20. Pediatr Infect Dis J. 2014. PMID: 24346596 Clinical Trial.
Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Hla KH, et al. Pediatr Infect Dis J. 2006 Aug;25(8):706-12. doi: 10.1097/01.inf.0000223488.80814.df. Pediatr Infect Dis J. 2006. PMID: 16874170 Clinical Trial.
Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
Faingezicht I, Avila-Aguerro ML, Cervantes Y, Fourneau M, Clemens SA. Faingezicht I, et al. Rev Panam Salud Publica. 2002 Oct;12(4):247-57. doi: 10.1590/s1020-49892002001000005. Rev Panam Salud Publica. 2002. PMID: 12431356 Clinical Trial.
A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.
Quiambao B, Van Der Meeren O, Kolhe D, Gatchalian S. Quiambao B, et al. Hum Vaccin Immunother. 2012 Mar;8(3):347-54. doi: 10.4161/hv.18630. Epub 2012 Feb 14. Hum Vaccin Immunother. 2012. PMID: 22330958 Free PMC article. Clinical Trial.
The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D. Gatchalian S, et al. Int J Infect Dis. 2008 May;12(3):278-88. doi: 10.1016/j.ijid.2007.08.007. Epub 2007 Nov 5. Int J Infect Dis. 2008. PMID: 17981067 Free article. Clinical Trial.
Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K. Marshall H, et al. Int J Infect Dis. 2010 Jan;14(1):e41-9. doi: 10.1016/j.ijid.2009.03.004. Epub 2009 May 20. Int J Infect Dis. 2010. PMID: 19467896 Free article. Clinical Trial.
Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
Sil A, Ravi MD, Patnaik BN, Dhingra MS, Dupuy M, Gandhi DJ, Dhaded SM, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Rout SP, Jayanth MV, D'Cor NA, Mangarule SA, Ravinuthala S, Reddy E J. Sil A, et al. Vaccine. 2017 May 19;35(22):2999-3006. doi: 10.1016/j.vaccine.2017.03.009. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449972 Free article. Clinical Trial.
Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.
Wong SL, Soosai P, Teoh YL, Han HH, Lefevre I, Bock HL. Wong SL, et al. Southeast Asian J Trop Med Public Health. 2008 May;39(3):474-83. Southeast Asian J Trop Med Public Health. 2008. PMID: 18564687 Clinical Trial.
116 results
Jump to page
Feedback